I now have comprehensive information from all sources. Let me compile the complete, exam-ready answer.
Anemia in Pregnancy and Anesthesia - Complete Viva Guide
1. DEFINITION AND INCIDENCE
Anemia in pregnancy is defined as a hemoglobin (Hb) below the lower limit of normal not explained by hydration status.
CDC/ACOG cutoffs:
| Trimester | Hb (g/dL) | Hct (%) |
|---|
| 1st | < 11.0 | < 33 |
| 2nd | < 10.5 | < 32 |
| 3rd | < 11.0 | < 33 |
Global prevalence: ~38% of pregnancies (43% in 1995, 38% by 2011). Iron deficiency causes ~50% of all cases. - Creasy & Resnik's Maternal-Fetal Medicine, p. 1329
2. WHO GRADES OF ANEMIA IN PREGNANCY (2024 Updated Guidelines)
| Grade | Hb (g/dL) |
|---|
| No anemia (normal) | ≥ 11.0 (1st/3rd trimester); ≥ 10.5 (2nd trimester) |
| Mild | 10.0-10.9 g/dL |
| Moderate | 7.0-9.9 g/dL |
| Severe | < 7.0 g/dL |
| Very severe / life-threatening | < 4.0 g/dL |
The
2024 WHO guideline on haemoglobin cutoffs updated these thresholds and stratifies by trimester.
Clinical grades of pallor (examination finding):
- Grade 1 (mild): Pallor of conjunctivae, inner lower eyelid
- Grade 2 (moderate): Conjunctival + palmar pallor
- Grade 3 (severe): Conjunctival + palmar + nail bed pallor
- Grade 4 (very severe): Generalized pallor - tongue, mucous membranes, skin, nail beds
3. PHYSIOLOGIC CHANGES OF PREGNANCY RELEVANT TO ANEMIA
Normal Hemodilution (Physiologic Anemia of Pregnancy)
- Plasma volume increases ~50% by term
- Red cell mass increases only 25-30%
- Net result: relative hemodilution; Hb falls by ~1.5-2 g/dL (nadir at ~28-32 weeks)
- This is NOT pathological - it reduces blood viscosity and improves uteroplacental perfusion
Key Systemic Changes in Pregnancy
| Parameter | Change |
|---|
| Cardiac output | +40-50% |
| Heart rate | +15-20 bpm |
| Stroke volume | Increased |
| Blood pressure | Slightly decreased (1st/2nd trimester) |
| Oxygen consumption | Increases to ~331 mL/min at rest (term); +40-60% in labor |
| FRC | Decreased 20% |
| 2,3-DPG | Increased (rightward ODC shift) |
| Serum ferritin | Decreased |
"Oxygen consumption increases steadily throughout pregnancy and is greatest at term, reaching an average of 331 mL/min at rest and 1167 mL/min with exercise." - Creasy & Resnik's, p. 1397
4. OXYGEN FLUX (DO2) - THE FICK PRINCIPLE
DO2 = CO × CaO2
Where: CaO2 = (Hb × 1.34 × SaO2) + (PaO2 × 0.003)
So: DO2 = CO × [(Hb × 1.34 × SaO2) + (PaO2 × 0.003)]
- Normal DO2: ~1000 mL/min; VO2 (consumption): ~250 mL/min
- Oxygen extraction ratio = VO2/DO2 = ~25% (large reserve)
- In anemia, CO compensates - in pregnancy DO2 is maintained because CO increases 50%
Critical DO2 (DO2crit): When DO2 falls below this threshold, oxygen consumption becomes supply-dependent. Tissues switch to anaerobic glycolysis - lactic acidosis ensues.
"The pregnant woman depends on cardiac output for maintenance of oxygen delivery more than the nonpregnant patient." - Creasy & Resnik's, p. 1397
Why this matters in anemia: Anemia reduces CaO2. If cardiac reserve is limited (e.g., pre-existing cardiac disease, hemorrhage), DO2 can fall below DO2crit, causing tissue hypoxia. In labor, oxygen consumption jumps +40-60% further narrowing the margin.
5. COMPENSATORY MECHANISMS IN ANEMIA
Three main mechanisms (from Harrison's Principles, 22e):
- Increased cardiac output (minutes) - heart rate and stroke volume rise; most rapid and effective
- Increased 2,3-DPG (hours to days) - stabilizes deoxy-Hb, rightward shift of ODC, enhances tissue O2 unloading (lower P50 → more O2 given up at same PO2)
- Plasma volume expansion (weeks) - maintains preload and cardiac output; can cause high-output cardiac failure if overwhelming
Additional compensation:
- Redistribution of blood flow to vital organs
- Renal EPO production increases
- Decreased blood viscosity → less resistance → improved flow
6. TYPES AND CAUSES OF ANEMIA IN PREGNANCY
Classification by Pathophysiologic Mechanism (Box 55.1, Creasy & Resnik)
A. Decreased Production (Hypoproliferative)
| Type | Cause |
|---|
| Iron deficiency anemia (IDA) | 75% of all anemias in pregnancy; depleted stores, high demand |
| Megaloblastic (Folate deficiency) | Commonest megaloblastic anemia in pregnancy; ↑ folate demand (RBC turnover, fetal needs) |
| Megaloblastic (B12 deficiency) | Pernicious anemia, strict vegetarians |
| Anemia of chronic disease | Chronic infection, inflammatory disease |
| Aplastic anemia | Bone marrow failure; pregnancy-induced or idiopathic |
| Hypoplastic anemia | |
B. Increased Destruction (Hemolytic)
| Type | Examples |
|---|
| Hereditary hemolytic | Sickle cell disease (HbSS), thalassemia, hereditary spherocytosis, G6PD deficiency |
| Acquired hemolytic | Autoimmune hemolytic anemia, HELLP syndrome, TTP, malaria, drug-induced |
C. Blood Loss
| Acute | Placenta previa, abruption, ruptured ectopic, postpartum hemorrhage |
| Chronic | Ankylostoma (hookworm), chronic GI loss |
Morphologic Classification
| MCV | Type | Causes |
|---|
| Microcytic (MCV < 80) | Hypochromic | IDA, thalassemia, sideroblastic anemia, anemia of chronic disease |
| Normocytic (MCV 80-100) | Normochromic | Acute blood loss, hemolytic anemia, aplastic anemia, early IDA |
| Macrocytic (MCV > 100) | Megaloblastic | Folate deficiency, B12 deficiency, drugs (methotrexate) |
7. SPECIFIC ANEMIAS IN DETAIL
Iron Deficiency Anemia (IDA)
- Most common (75% of pregnancy anemias)
- Symptoms: fatigue, lethargy, pica (ice, clay, dirt), pallor, glossitis, cheilitis, koilonychia (rare)
- Labs: microcytic hypochromic, low serum iron, high TIBC, low ferritin (< 12 µg/L), low transferrin saturation
- Treatment: Ferrous sulfate 325 mg OD-TID; WHO recommends 60 mg elemental iron/day with folic acid; IV iron if severe/intolerant (iron sucrose preferred)
- Reticulocytosis expected at 7-10 days; Hb rises ~1 g/dL/week in severe anemia - Creasy & Resnik's, p. 1335
Folate Deficiency (Megaloblastic)
- Second most common in pregnancy
- Causes: inadequate dietary intake, malabsorption, multiple pregnancy, folate antagonists (methotrexate, trimethoprim, pyrimethamine)
- Labs: macrocytic, hypersegmented neutrophils, low serum and RBC folate
- Treatment: Folic acid 5 mg OD; prevention: 400 µg/day preconceptionally
B12 Deficiency
- Pernicious anemia (anti-intrinsic factor antibodies), strict vegetarians, prior gastric surgery
- Labs: macrocytic, elevated MMA and homocysteine
- Treatment: IM cyanocobalamin or hydroxycobalamin
Sickle Cell Disease in Pregnancy
- Hb SS, SC, S-β-thal
- Complications: vaso-occlusive crisis, acute chest syndrome, stroke, splenic sequestration, increased UTI, preeclampsia, preterm labor
- Triggers for sickling: hypoxia, hypovolemia, hypothermia, acidosis, infection, dehydration
- Transfusion goals: Hb > 8 g/dL, HbA > 40% of total Hb
- Frequency of sickle cell trait: 1:122 in African-Americans
Thalassemia
- Alpha-thalassemia minor: mild hypochromic microcytic anemia; tolerated in pregnancy
- Beta-thalassemia major (Cooley's anemia): severe transfusion-dependent; iron overload; cardiomyopathy
- Beta-thalassemia trait: mild microcytic anemia; must distinguish from IDA (serum ferritin, Hb electrophoresis)
8. EFFECTS OF ANEMIA ON MOTHER AND FETUS
Maternal:
- High output cardiac failure in severe anemia
- Reduced tolerance for hemorrhage at delivery
- Postpartum hemorrhage risk is 3-15x higher (mild to severe anemia)
- Placental abruption risk increased
- Increased susceptibility to infection
- Preeclampsia association
Fetal:
- Preterm birth, SGA, low birth weight, perinatal death - risk increases with severity
- Poor cognitive development in children born of iron-deficient mothers
- Elevated maternal Hb (>14.5 g/dL) is also associated with poor outcomes (reduced plasma expansion, placental dysfunction)
- Note: Fetal O2 consumption maintained until maternal Hct reduced by >50% (sheep model)
9. INVESTIGATION OF ANEMIA IN PREGNANCY
Routine:
- CBC, reticulocyte count, peripheral smear
- Serum ferritin (best single test for iron stores - but is an acute phase reactant)
- Serum iron, TIBC, transferrin saturation
- Folate (serum + RBC) and B12 levels
When indicated:
- Hb electrophoresis (sickle cell, thalassemia)
- Direct Coombs test (hemolytic)
- LDH, haptoglobin, bilirubin (hemolysis screen)
- Reticulocyte production index (RPI = reticulocyte % × Hct/45 ÷ maturation time)
| Test | IDA | ACD | Hemolytic | Megaloblastic |
|---|
| MCV | Low | Low-Normal | Normal/High | High |
| Serum iron | Low | Low | Normal | Normal |
| TIBC | High | Low-Normal | Normal | Normal |
| Ferritin | Low | Normal-High | Normal | Normal |
| Reticulocyte | Low | Low | High | Low |
10. ANESTHESIA MANAGEMENT IN ANEMIA IN PREGNANCY
Preoperative Assessment
- Assess severity: Hb, Hct, peripheral smear, reticulocyte count
- Assess compensation: Resting tachycardia, orthopnea, signs of cardiac failure, functional status
- Identify cause: See above workup
- Assess concomitant disease: Cardiac reserve, coagulopathy (in thalassemia/aplastic anemia), platelet count (for neuraxial)
- Blood bank: Group & crossmatch, ensure availability of packed RBCs
"The concept of an acceptable Hb level varies with the underlying medical condition, extent of physiological compensation, the threat of bleeding and ongoing blood losses." - Anaemia and Pregnancy: Anaesthetic Implications, PMC2991646
Minimum Acceptable Hemoglobin for Anesthesia
- Elective surgery: Hb ≥ 8 g/dL generally acceptable (individualized)
- Obstetric surgery (LSCS): Pre-transfusion target Hb ≥ 8-10 g/dL; historically 10 g/dL ("10/30 rule") but evidence for this is not conclusive
- Emergency surgery: Proceed with resuscitation, transfuse intraoperatively
Preoperative Optimization (Elective)
- Mild-moderate IDA: Oral iron for 2-4 weeks to raise Hb by 1-2 g/dL before elective surgery
- Severe IDA or intolerance to oral: IV iron sucrose 200-300 mg over 30-60 min (faster response)
- Folate/B12 deficiency: Treat cause, start supplementation
- Very severe anemia (Hb < 6): Pre-operative transfusion - packed red cells
- Treat underlying cause, optimize nutrition, ensure euvolemia
Key Anesthetic Goals (Both GA and RA)
- Minimize O2 consumption - avoid pain, shivering, anxiety (increase O2 demand)
- Maximize O2 delivery - maximize FiO2, ensure adequate CO, avoid hypotension
- Avoid conditions shifting ODC LEFT (would impair O2 unloading):
- Hypothermia
- Respiratory alkalosis (hyperventilation) - keep normocarbia
- Alkalemia
- Hypophosphatemia
- Maintain cardiac output - aggressive fluid management, vasopressors for spinal hypotension
- Warm all IV fluids and blood products
- Prevent blood loss - meticulous hemostasis, tranexamic acid, cell salvage where appropriate
Choice of Anesthetic Technique
Regional Anesthesia (Preferred where feasible):
- Spinal or epidural/CSE for LSCS is preferred in anemia
- Advantages: avoids airway manipulation, reduces blood loss vs GA, provides good post-op analgesia
- Spinal precautions: Use low-dose spinal + adjuvants (fentanyl/morphine) to minimize sympathectomy and hypotension
- Treat spinal hypotension aggressively: left uterine displacement, IV fluids, vasopressors (phenylephrine/ephedrine)
- Check platelet count before neuraxial block (> 80,000 generally acceptable; > 100,000 preferred)
General Anesthesia:
- Required for: severe thrombocytopenia, coagulopathy, patient refusal of RA, failed RA, emergency with unstable patient
- Key considerations in anemia:
- Pre-oxygenate thoroughly (FRC already reduced in pregnancy)
- Rapid sequence induction (full stomach precaution)
- Use etomidate or ketamine for induction if hemodynamically compromised (avoid propofol in severe anemia - myocardial depression, risk of hypotension)
- Maintenance: volatile agents are myocardial depressants - use with care; nitrous oxide can be used but avoid in folate/B12 deficiency (inhibits methionine synthase)
- Avoid barbiturates for induction in severe anemia (reduced dose requirements, more prone to hypotension)
- Maintain normothermia, normocarbia
- Avoid N2O in megaloblastic anemia
Monitoring in Severe Anemia
- Standard: ECG, NIBP, SpO2, EtCO2, temperature
- Consider invasive monitoring in severe anemia with anticipated major blood loss:
- Arterial line (continuous BP, serial ABG, Hb monitoring)
- CVP
- Urinary catheter (hourly output)
- ABG (pH, lactate, Hb, base excess)
- Mixed venous O2 saturation (SvO2) in critical cases
Intraoperative Management
- Maintain FiO2 0.4-1.0 (based on severity)
- Warm all IV fluids and blood products
- Aggressive uterotonic management postpartum (syntocinon, ergometrine, carboprost)
- Activate massive obstetric hemorrhage protocol early if bleeding
- Transfusion trigger: Hb < 7-8 g/dL in stable patient; transfuse at higher threshold if symptomatic, ongoing bleeding, or cardiac compromise
- Target: Hb ≥ 8 g/dL, normothermia, pH > 7.35, calcium > 1.1 mmol/L
Special Anesthetic Considerations by Type
Sickle Cell Disease:
- Avoid: hypoxia, hypovolemia, hypothermia, acidosis, stasis, infection
- Regional anesthesia preferred (avoids catecholamine surge, maintains warmth)
- Both neuraxial and GA acceptable if above triggers avoided
- Pre-operative transfusion goal: Hb > 8 g/dL, HbA > 40%
- Avoid tourniquets; maintain hydration
Thalassemia Major:
- Iron overload → cardiomyopathy → reduced cardiac reserve
- Difficult airway possible (hepatosplenomegaly may push diaphragm; maxillary changes from bone marrow expansion)
- Both GA and neuraxial acceptable after platelet count review
- Avoid further iron loading (no unnecessary transfusions)
- Echocardiography preoperatively to assess cardiac function
Aplastic Anemia:
- Pancytopenia: anemia + thrombocytopenia + neutropenia
- Thrombocytopenia may preclude neuraxial anesthesia → GA often required
- Platelet transfusion preoperatively to target > 50,000 (neuraxial) or > 100,000 (platelet-rich field)
- Extreme care with infection prevention (neutropenia)
- GA with meticulous aseptic technique
Hemolytic Anemia (e.g., Hereditary Spherocytosis, AIHA):
- Monitor for hemolytic crisis perioperatively
- Regional anesthesia preferred (reduces perioperative stress)
- Avoid blood stasis, hypothermia, oxidant drugs in G6PD deficiency
- In G6PD: avoid methylene blue, primaquine, nitrofurantoin, dapsone
Postoperative Care
- Continue oxygen supplementation (SpO2 monitoring)
- Adequate analgesia (reduces O2 consumption from pain response)
- Vigilance for postpartum hemorrhage (reduced uterine contractility in severe anemia)
- Continue oral/IV iron supplementation
- Monitor Hb at 24 hours post-delivery
- Delayed cord clamping at delivery to maximize neonatal iron transfer
11. QUICK VIVA SUMMARY TABLE
| Parameter | Value/Key Point |
|---|
| Definition (CDC) | Hb < 11 g/dL (1st/3rd), < 10.5 (2nd trimester) |
| Most common cause | Iron deficiency (75%) |
| Physiologic anemia | Plasma vol +50%, RBC mass +25% → hemodilution |
| Oxygen flux formula | DO2 = CO × (Hb × 1.34 × SaO2) |
| Compensatory mechanisms | ↑CO, ↑2,3-DPG (rightward shift), ↑plasma volume |
| WHO severe anemia | Hb < 7.0 g/dL |
| Minimum Hb for elective LSCS | ≥ 8-10 g/dL |
| Preferred anesthetic technique | Regional (spinal/CSE) |
| Avoid in GA for anemia | Hyperventilation, hypothermia, hypotension |
| Avoid N2O in | Folate/B12 deficiency megaloblastic anemia |
| Transfusion trigger (stable) | Hb < 7-8 g/dL |
| Sickle cell avoidance | Hypoxia, hypothermia, acidosis, dehydration |
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Harrison's Principles of Internal Medicine 22e; Goldman-Cecil Medicine; Barash's Clinical Anesthesia 9e;
Anaemia and Pregnancy: Anaesthetic Implications (PMC2991646);
WHO 2024 Haemoglobin Cutoffs Guideline